Here are 23 key notes on orthopedic and spine device companies over the past week.
Lenox Hill Hospital in New York is conducting a VENUS clinical trial for Active Implants' NUsurface Meniscus Implant.
Amedica submitted 24-month clinical outcomes data from its CASCADE study to the FDA.
The 500th knee surgery was performed with the Navio robotic system from Blue Belt Technologies at Cornerstone Regional Hospital in South Texas.
Collagen Matrix will participate in the FDA's Experiential Learning Program.
DJO Global reported a 1.8 percent decrease in third quarter net sales.
The United States Patent and Trademark Office granted Intellijoint Surgical a key patent related to its core technology in miniature 3D surgical measurement.
Interventional Spine received FDA clearance for its Opticage Expandable Interbody Fusion device.
Materialise's hip guide system received FDA approval.
St. Mary's Medical Center in San Francisco has implemented Mazor Robotics' Renaissance Guidance System.
Mazor Robotics presented data for its PROlif Lateral solution and demonstrated a procedure on a cadaver at the Society for Minimally Invasive Spine Surgery Global Forum '15 in Las Vegas.
Medtech received Frost & Sullivan's Excellence in Best Practices award.
Medovex entered into an advisory board member consulting agreement with spine surgeon Vik Kapoor, MBBS, from the United Kingdom.
Medovex successfully completed a loan transaction with the company’s co-founder, Steven Gorlin.
Misonix trained more than 50 spine surgeons in the use of its BoneScalpel MIS Platform at the Society for Minimally Invasive Spine Surgery meeting in Las Vegas.
Physicians at Alvarado Hospital in San Diego successfully performed a total knee replacement surgery using OMNIBotics Robotic-Assisted system.
Orthofix reported a 4.1 percent increase in Q3 2015 net sales, hitting $101.2 million.
Orthofix insider Jeffrey Schumm sold 15,000 shares of the company in a recent transaction.
Orthozon signed a distribution agreement appointing GM Medical Pacific the exclusive distributor of its LUMIERE Minimally Invasive Access System in the Asia-Pacific region.
The FDA has cleared SI-BONE's iFuse Implant System to include an updated indication statement.
TranS1's AxiaLIF procedures could save the healthcare system thousands per procedure, according to a new economic analysis.
Vericel has signed a long-term supply agreement with Matricel.
VertiFlex received approval from the AMA CPT Editorial Panel to add Category I CPT codes to describe one- and two-level insertion of interspinous spacers.
Xtant Medical reported a revenue increase of 6.5 percent in the third quarter of 2015, over the same period last year.